Lawrence Russell Smith - Net Worth and Insider Trading
Lawrence Russell Smith Net Worth
The estimated net worth of Lawrence Russell Smith is at least $41 dollars as of 2024-11-13. Lawrence Russell Smith is the VP, Vaccine Research of Fresh Tracks Therapeutics Inc and owns about 56 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $41. Details can be seen in Lawrence Russell Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lawrence Russell Smith has not made any transactions after 2017-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lawrence Russell Smith
Lawrence Russell Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lawrence Russell Smith owns 1 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) .
Click here to see the complete history of Lawrence Russell Smith’s form 4 insider trades.
Insider Ownership Summary of Lawrence Russell Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2017-03-15 | VP & Vaccine Research |
Lawrence Russell Smith Latest Holdings Summary
Lawrence Russell Smith currently owns a total of 1 stock. Lawrence Russell Smith owns 56 shares of Fresh Tracks Therapeutics Inc (FRTX) as of March 15, 2017, with a value of $41.
Latest Holdings of Lawrence Russell Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2017-03-15 | 56 | 0.74 | 41 |
Holding Weightings of Lawrence Russell Smith
Lawrence Russell Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Lawrence Russell Smith has made a total of 0 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years. The most-recent trade in Fresh Tracks Therapeutics Inc is the sale of 3 shares on March 15, 2017, which brought Lawrence Russell Smith around $2,021.
Insider Trading History of Lawrence Russell Smith
- 1
Lawrence Russell Smith Trading Performance
Lawrence Russell Smith Ownership Network
Ownership Network List of Lawrence Russell Smith
Ownership Network Relation of Lawrence Russell Smith
Lawrence Russell Smith Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Lawrence Russell Smith is the VP & Vaccine Research of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Lawrence Russell Smith made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
Lawrence Russell Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Lawrence Russell Smith. You might contact Lawrence Russell Smith via mailing address: C/o Vical Incorporated, 10390 Pacific Center Court, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
